NFE2L2 and metabolic dysfunction-associated steatotic liver disease: In detail, in NAFLD subjects, butyrate-producing probiotics reduce the accumulation of lipids in the liver by improving hepatic resistance to insulin through the activation of AMP-activated protein kinase (AMPK), and the expression of factor-related erythroid nuclear factor 2 2 (Nrf2) in rats with NAFLD.